(Adnkronos) – "Today we are presenting a Manifesto developed with respiratory patient associations, focusing on severe asthma and nasal polyposis, complex conditions for which multidisciplinary dialogue between the various professionals involved in patient care is essential." Eleonora Selvi, president of the Longevitas Foundation, spoke today at the Ministry of Health Auditorium in Rome during the Foundation's institutional conference dedicated to therapeutic adherence and the contribution of ultra-long-acting therapies in chronic respiratory diseases, such as severe asthma and nasal polyposis.
We hope that the 'Time for Care' Manifesto will be adopted and signed by the institutions and become a guide to simplify and reduce access times in the various regions. The key issue is also that of equity, avoiding having citizens divided by zip code. When innovation arrives, it must be easily accessible. Today, in the management of chronic diseases, we cannot focus solely on clinical outcomes: we must focus on people's overall quality of life.
In this case, this means, for example, quality of sleep, quality of smell, and simplicity of treatment plans when talking to professionals,” he added.
"Innovation is crucial, especially in a rapidly aging population like the Italian one. Rapid and timely access to innovative treatments not only means better health outcomes, but often also a simplification of life," Selvi emphasized.
For the president of the Longevitas Foundation, "innovation concerns not only the pharmacological field but also simpler care models and treatment plans, which are particularly important for vulnerable individuals and those requiring caregiver support. Reducing the frequency and complexity of administrations can improve quality of life and free up time for personal and family life," she concluded.
News
webinfo@adnkronos.com (Web Info)
